Successful Long-term Use of Intravenous Immunoglobulin to Treat Livedoid Vasculopathy Associated With Plasminogen Activator Inhibitor-1 Promoter Homozygosity

Livedoid Vasculopathy ◽

Plasminogen Activator Inhibitor-1 Deficiency Prevents Hypertension and Vascular Fibrosis in Response to Long-term Nitric Oxide Synthase Inhibition

Circulation ◽

10.1161/hc3301.092803 ◽

2001 ◽

Vol 104 (7) ◽

pp. 839-844 ◽

Cited By ~ 115

Author(s):

Koichi Kaikita ◽

Agnes B. Fogo ◽

Lijun Ma ◽

John A. Schoenhard ◽

Nancy J. Brown ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Plasminogen Activator ◽

Oxide Synthase ◽

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease

European Journal of Clinical Pharmacology ◽

10.1007/bf00192563 ◽

1994 ◽

Vol 46 (3) ◽

Cited By ~ 4

Author(s):

R.A. Wright ◽

A.M. Perrie ◽

F. Stenhouse ◽

K.G.M.M. Alberti ◽

R.A. Riemersma ◽

...

Keyword(s):

Heart Disease ◽

Plasminogen Activator ◽

Tissue Type ◽

Long Term Effects ◽

Tissue Type Plasminogen Activator ◽

Type Plasminogen Activator ◽

Livedoid Vasculopathy Associated With Plasminogen Activator Inhibitor-1 Promoter Homozygosity (4G/4G) Treated Successfully With Tissue Plasminogen Activator

Archives of Dermatology ◽

10.1001/archderm.142.11.1466 ◽

2006 ◽

Vol 142 (11) ◽

Cited By ~ 29

Author(s):

April Deng ◽

Christopher D. Gocke ◽

John Hess ◽

Meyer Heyman ◽

Michael Paltiel ◽

...

Keyword(s):

Plasminogen Activator ◽

Tissue Plasminogen Activator ◽

Livedoid Vasculopathy ◽

Tissue Plasminogen ◽

Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-011-0556-y ◽

2011 ◽

Vol 32 (1) ◽

pp. 59-63 ◽

Cited By ~ 12

Author(s):

Mehmet Agirbasli ◽

Mesut Eren ◽

Fatih Eren ◽

Sheila B. Murphy ◽

Zehra A. Serdar ◽

...

Keyword(s):

Plasminogen Activator ◽

Functional Stability ◽

Livedoid Vasculopathy ◽

Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions

Cardiovascular Therapeutics ◽

10.1111/1755-5922.12255 ◽

2017 ◽

Vol 35 (3) ◽

pp. e12255 ◽

Cited By ~ 1

Author(s):

Mehmet Agirbasli ◽

Fatih Göktay ◽

Irem Peker ◽

Pembegul Gunes ◽

Fugen Vardar Aker ◽

...

Keyword(s):

Mrna Expression ◽

Plasminogen Activator ◽

Livedoid Vasculopathy ◽

Plasminogen activator inhibitor‐1: a potential etiological role in livedoid vasculopathy

International Wound Journal ◽

10.1111/iwj.13480 ◽

2020 ◽

Vol 17 (6) ◽

pp. 1902-1908

Author(s):

Yimeng Gao ◽

Hongzhong Jin

Keyword(s):

Plasminogen Activator ◽

Etiological Role ◽

Livedoid Vasculopathy ◽

Livedoid Vasculopathy Associated with Plasminogen Activator Inhibitor-1 Promoter Homozygosity (4G/4G) and Prothrombin G20210A Heterozygosity: Response to t-PA Therapy

Acta Dermato Venereologica ◽

10.2340/00015555-0760 ◽

2010 ◽

Vol 90 (1) ◽

pp. 91-92 ◽

Cited By ~ 6

Author(s):

J Antunes ◽

P Filipe ◽

M André ◽

A Fraga ◽

G Miltenyi ◽

...

Keyword(s):

Plasminogen Activator ◽

Prothrombin G20210a ◽

Livedoid Vasculopathy ◽

Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction

Coronary Artery Disease ◽

10.1097/00019501-199705000-00005 ◽

1997 ◽

Vol 8 (5) ◽

pp. 283-292 ◽

Cited By ~ 16

Author(s):

Ole Dyg Pedersen ◽

Jørgen Gram ◽

Xavier Jeunemaitre ◽

Eliane Billaud ◽

Jørgen Jespersen

Keyword(s):

Plasminogen Activator ◽

Tissue Type ◽

Angiotensin Converting Enzyme Inhibition ◽

Previous Myocardial Infarction ◽

Type Plasminogen Activator ◽

Converting Enzyme Inhibition ◽

Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2005.10.010 ◽

2006 ◽

Vol 125 (2) ◽

pp. 217-220 ◽

Cited By ~ 2

Author(s):

Anne Kalela ◽

Hannu Jokela ◽

Terho Lehtimäki ◽

Helena Uppa ◽

Tarja Kunnas ◽

...

Keyword(s):

Hormone Replacement Therapy ◽

Replacement Therapy ◽

Plasminogen Activator ◽

Hormone Replacement ◽

943: Plasminogen Activator Inhibitor 1 (PAI-1) is Increased in Human Peyronie's Disease

The Journal of Urology ◽

10.1016/s0022-5347(18)35099-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 255-255 ◽

Cited By ~ 1

Author(s):

Hugo H. Davila ◽

Thomas R. Magee ◽

Freddy Zuniga ◽

Jacob Rajfer ◽

Nestor F. GonzalezCadavid

Keyword(s):

Plasminogen Activator ◽

Peyronie’S Disease ◽

Peyronie's Disease ◽

Activator Inhibitor ◽

Pai 1